| Log in
Photo Credit: Thinkstock

Exclusive: Actis in talks with marquee PE firms, pharma co to sell Symbiotec stake

13 April, 2017

Private equity (PE) firm Actis Advisers Pvt. Ltd. has engaged an investment bank for the sale of its majority stake in Symbiotec Pharmalab Pvt. Ltd and has recently shortlisted a f ....

To read the Full Story

Definitive news, exclusives, analyses and videos

  • Exclusive reporting, expert analysis and commentary on PE/VC/M&A deals & dealmakers
  • Daily, weekly and monthly curated newsletters on the deal ecosystem in India
  • Breaking news alerts
  • Participation in marquee events at concessional rates

Comprehensive | Accurate | Unbiased | Impeccably sourced


Leave Your Comment
Exclusive: Symbiotec Pharmalab gets interest from new set of PE firms

Exclusive: Symbiotec Pharmalab gets interest from new set of PE firms

Ranjani R 5 months ago
Symbiotec Pharmalab Pvt. Ltd has attracted interest from a new set of global...
Actis elicits interest from investors for stake in Symbiotec Pharmalab

Actis elicits interest from investors for stake in Symbiotec Pharmalab

Ranjani R 1 year ago
Private equity firm Actis Capital, which invested in Symbiotec Pharmalab in...
Franklin Templeton Invests Rs 45Cr In Indore-based Symbiotec Pharmalab

Franklin Templeton Invests Rs 45Cr In Indore-based Symbiotec Pharmalab

Anil Das 6 years ago
Franklin Templeton Private Equity Strategy, a private equity portfolio managed...
No Comments

Exclusive: Actis in talks with marquee PE firms, pharma co to sell Symbiotec stake

Powered by WordPress.com VIP